Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Curium to acquire Lantheus in all-cash deal worth up to $8bn | PharmaVoice

Pharma Tech

Curium to acquire Lantheus in all-cash deal worth up to $8bn

Aug 4, 2026, 8:43 AM

Read Full Article → Curium to acquire Lantheus in all-cash deal worth up to $8bn

Curium to acquire Lantheus in all-cash deal worth up to $8bn

Translate article text

Choose a language and wait for the translated text.

CapVest Partners-backed Curium has agreed to acquire rival US-based radiopharmaceutical company Lantheus in an all-cash deal worth up to nearly $8bn.